Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
Change company Symbol lookup
Select an option...
CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
FRC First Republic Bank
NBSTU Newbury Street Acquisition Corp
AGFY Agrify Corp
SCE-K SCE Trust V
FAMI Farmmi Inc
HEEVF Helium Evolution Inc
DHR-B Danaher Corp
VLN Valens Semiconductor Ltd
GETY Getty Images Holdings Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta-cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. Its products include Trappsol HPB and Trappsol other product. The Company also operates a fine chemical business, consisting of the sale of cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Closing Price
$1.05
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.05
Day's Low
1.05
Volume
(Heavy Day)
Volume:
500

10-day average volume:
500
500
  • Prev Close
    1.05
  • Today's Open
    1.05
  • Day's Range
    1.05-1.05
  • Avg Vol (10-day)
    500
  • Last (time)
    12:04p ET 09/30/22
  • Last (size)
    1
  • 52-Wk Range
    0.35 - 3.07
    LowHigh
  • (10/15/21 - 09/30/22)
    200.00%
  • 198.8%
  • Market Cap
    0
  • Shares Outstanding
    --
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.